Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2561 stock hub

HKG/2561 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2561is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2561

In the news

Latest news · HKG/2561

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-50.5

P25 -14.7P50 2P75 9.4

ROIC-25.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2561 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

CNY

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	82
Employees Change	24%
Employees Change Percent	41.38
Enterprise value	HKD 2.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG93Y5D1039
Last refreshed	2026-05-10
Market cap	HKD 2.7B
Price	HKD 25.34
Price currency	HKD
Rev Per Employee	1,845.63x
Sector	Healthcare
Sic	2836
Symbol	hkg/2561
Website	https://www.visenpharma.com/cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.32%
EV Earnings	-7.89x
P/B ratio	3.22x
P/S ratio	18,054.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-7.35%
Gross Profit	HKD -11,128
Net Income	HKD -282M
Net Income Growth Years	0%
Pretax Margin	-186,339.94%
Profit Per Employee	HKD -3.4M
ROA	-23.58
ROCE	-31.29
ROE	-50.52
ROIC	-25.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.82%
EPS Growth Years	0
Revenue Growth	-95.1x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0
Assets	HKD 1.1B
Cash	HKD 704M
Current Assets	HKD 1.1B
Current Liabilities	HKD 242.9M
Debt	HKD 197M
Debt Equity	HKD 0.23
Equity	HKD 848M
Interest Coverage	-218.4
Liabilities	HKD 239.5M
Long Term Assets	HKD 2.7M
Long Term Liabilities	HKD -3.4M
Net Cash	HKD 507.1M
Net Cash By Market Cap	HKD 18.56
Net Debt Equity	HKD -0.6
Tangible Book Value	HKD 846.8M
Tangible Book Value Per Share	HKD 7.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.47
Net Working Capital	HKD 301.7M
Quick ratio	3
Working Capital	HKD 813.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-44.79%
200-day SMA	36.69
50-day SMA	27.84
50-day SMA vs 200-day SMA	50under200
All Time High	69.15
All Time High Change	-63.36%
All Time High Date	2025-03-21
All Time Low	24
All Time Low Change	5.58%
All Time Low Date	2026-03-24
ATR	1.49
Beta1y	0.82
Beta2y	1.03
Ch YTD	-22.74
High	25.84
High52	54
High52 Date	2025-06-16
High52ch	-53.07%
Low	24.1
Low52	24
Low52 Date	2026-04-09
Low52ch	5.58%
Ma50ch	-8.99%
Price vs 200-day SMA	-30.94%
RSI	43.51
RSI Monthly	19.05
RSI Weekly	29.57
Sharpe ratio	-1.22x
Sortino ratio	-1.55
Total Return	-10.71%
Tr YTD	-22.74
Tr1m	2.26%
Tr1w	0.96%
Tr3m	-25.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -266.9M
Operating margin	-176,339.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,405,686%
Shares Insiders	4.88%
Shares Out	109,035,364
Shares Qo Q	7.23%
Shares Yo Y	10.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	17,010x
Bv Per Share	7.78
Ch1m	2.26
Ch1w	0.96
Ch1y	-44.79
Ch3m	-25.47
Ch6m	-30.5
Change	-1.93%
Change From Open	-1.93
Close	25.84
Days Gap	0
Depreciation Amortization	824,519.1
Dollar Volume	445,984
Earnings Date	2026-05-15
EBIT	HKD -266.9M
EBITDA	HKD -266.1M
EPS	HKD -2.72
F Score	0
Fiscal Year End	December
Founded	2,018
Is Primary Listing	1
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Ma150	33.4
Ma150ch	-24.14%
Ma20	25.77
Ma20ch	-1.66%
Next Earnings Date	2026-05-15
Open	25.84
Position In Range	71.26
Ppne	8,863,580.8
Price Date	2026-05-08
Ptbv Ratio	3.23
Relative Volume	0.93x
Revenue	151,342x
Tr6m	-30.5%
Volume	17,600

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2561 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2561 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2561?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+4.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.7%

Negative means the company is buying back shares.

Technical

HKG/2561 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.5

Neutral momentum band

Price vs 200-day MA

-30.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2561

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2561 stock rating?

hkg/2561 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2561 analysis?

The full report lives at /stocks/hkg/2561/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2561?

The latest report frames hkg/2561 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2561 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.